Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 912 results for "bristol"

Europe's largest street art and graffiti festival | Photos

Bristol, the home of Banksy, opens its walls to street art. It' called Upfest 2015 - and it's the largest street art and graffiti festival in Europe. The three-day annual event in Bristol, England, started in 2008. It now attracts more than 250 ... Grenfell Record, 1 hour ago
In pictures: Street art festival BBC, 11 hours ago
[x]  

22,218 images for bristol

EckhoBristol, 1 day ago
EckhoBristol, 1 day ago
EckhoBristol, 1 day ago
Lancaster & Morecambe Citizen, 19 hours ago
One News Page United Kingdom, 8 hours ago
One News Page United Kingdom, 9 hours ago
One News Page United Kingdom, 11 hours ago
Zip06.com, 8 hours ago
TurnTo10.com, 1 day ago
AM Online, 3 days ago

Bristol-Myers receives FDA breakthrough therapy designation for HIV-1 drug

Bristol-Myers Squibb Company has received breakthrough therapy designation from the FDA for the investigational compound, BMS-663068, when used in combination with other antiretroviral, or ARV, agents for the treatment of HIV-1 infection in heavily ...
 Individual.com3 hours ago Brokerages Set Bristol-Myers Squibb Target Price at $65.79 (NYSE:BMY)  Mideast Time1 day ago Bristol-Myers Squibb Garners U.S. FDA Breakthrough Therapy Designation [Professional Services Close - Up]  Pharmacy Choice14 hours ago Bristol Myers Squibb : Garners U.S. FDA Breakthrough Therapy Designation  4 Traders18 hours ago
[x]  
Facilities Management Journal

FDA Approves Daclatasvir (Daklinza) for Chronic Hepatitis C Genotype 3 Infections

The FDA has approved daclatasvir (Daklinza, Bristol-Myers Squibb) for use with sofosbuvir (Sovaldi, Gilead Sciences) to treat patients with hepatitis C virus (HCV) genotype 3 infections. Daclatasvir is the first drug that has demonstrated safety and ...
 P&T Community6 hours ago JLL scores FM deal with Bristol-Myers in the USA  Facilities Management Journal10 hours ago Chronic HCV genotype 3 drug approved  Pharmacist.com11 hours ago EMA accepts Bristol-Myers' Empliciti MAA under accelerated review  TeleTrader.com11 hours ago
[x]  
Motley Fool

BRISTOL MYERS SQUIBB : Gets European Commission Approval of Nivolumab BMS

Bristol-Myers Squibb Company reported that the European Commission has approved Nivolumab BMS for the treatment of locally advanced or metastatic squamous (SQ) non-small cell lung cancer (NSCLC) after prior chemotherapy. According to a media ...
 4 Traders18 hours ago Bristol-Myers Squibb Gets a Mixed Message From Investors  Motley Fool4 days ago Bristol-Myers receives European Commission approval for HIV-1 infection drug  Individual.com4 days ago Bristol Myers Squibb : Secures European Commission Approval of Nivolumab BMS  4 Traders3 days ago
[x]  

Look for Shares of Bristol-Myers Squibb to Potentially Rebound after Yesterday's 2.55% Sell Off

(Comtex SmarTrend(R)) Bristol-Myers Squibb (NYSE:BMY) traded in a range yesterday that spanned from a low of $64.29 to a high of $65.70. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $65.98 on volume of 8.1 ...
 Individual.com4 hours ago SmarTrend Watching for Potential Rebound in Shares of Bristol-Myers Squibb After 2.55% Loss  Individual.com4 hours ago
ITV.com

EXCLUSIVE: Daddy G talks to us about his disappearance

A member of the Bristol band Massive Attack has added his voice to the campaign to find the missing Bristol DJ Derek Morris. Daddy G of Massive Attack spoke to us exclusively about his missing friend - but says he isn't worried as the DJ doesn't ...
 ITV.com8 hours ago Family start poster campaign to find DJ Derek  ITV.com9 hours ago Bristol's DJ Derek missing for three weeks  ITV.com3 days ago Growing concern for Bristol's DJ Derek who has not been seen for three weeks  ITV.com3 days ago

Bristol-Myers Squibb announces encouraging data from Phase IIa HIV study

Bristol-Myers Squibb Company has announced encouraging data from a Phase IIa proof-of-concept study with BMS-955176, a novel investigational agent designed to prevent the maturation of HIV-1. The study findings confirmed the antiretroviral activity ...
 Individual.com3 hours ago
International Business Times UK

Maisie Moran: Police search under way for missing 14-year-old Bristol girl

Police are searching for missing Bristol teenager Maisie Moran, who was last on 25 July in the St Werburgh's Park area of the city at about 9.45pm. Fourteen-year-old Maisie is described as white, 5ft 7in and of medium build with short brown hair.
 International Business Times UK14 hours ago Missing Maisie Moran  ITV.com15 hours ago Teenage girl goes missing in Bristol  ITV.com15 hours ago

Bristol gets tough on tagging, but is it art or vandalism?

Partly thanks to the international notoriety of street artist Banksy, who comes from the city, Bristol has earned itself a reputation for its street art. The city has embraced this: visitors can go on walking tours of famous street artworks , for ...
 Lexology5 hours ago

Potential Bristol Myers (BMY) Trade Has 4.20% Downside Protection

Bristol-Myers Squibb Co (http://www.marketintelligencecenter.com/symbol/BMY"BMY) is an excellent choice for either a diagonal spread or a covered call expiring in Sep. '15 at the $65.00 level according to MarketIntelligenceCenter.comaEUR(TM)s ...
 Individual.com7 hours ago Bristol Myers (BMY) Showing Bullish Technicals With Support At $67.97  Individual.com5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - bristol
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less